Cargando…

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status

INTRODUCTION: Few studies have examined memory decline among patients with type 2 diabetes using different oral hypoglycemic drugs. METHODS: Participants with normal cognition (NC) or Alzheimer's disease (AD) dementia using a hypoglycemic medication (2005 to 2019) were identified from the Natio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Che‐Yuan, Ouk, Michael, Wong, Yuen Yan, Anita, Natasha Z., Edwards, Jodi D., Yang, Pearl, Shah, Baiju R., Herrmann, Nathan, Lanctôt, Krista L., Kapral, Moira K., MacIntosh, Bradley J., Rabin, Jennifer S., Black, Sandra E., Swardfager, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754496/ https://www.ncbi.nlm.nih.gov/pubmed/32803865 http://dx.doi.org/10.1002/alz.12161

Ejemplares similares

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
por: Ouk, Michael, et al.
Publicado: (2021)

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
por: Wu, Che‐Yuan, et al.
Publicado: (2022)

Diabetes Mellitus Is Associated With Poor In‐Hospital and Long‐Term Outcomes in Young and Midlife Stroke Survivors
por: MacIntosh, Bradley J., et al.
Publicado: (2021)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease
por: Cogo‐Moreira, Hugo, et al.
Publicado: (2023)

Questioning the Meaning of a Change on the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over Time
por: Cogo-Moreira, Hugo, et al.
Publicado: (2020)

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
por: Bawa, Kritleen K., et al.
Publicado: (2020)

Cardiopulmonary Fitness Correlates with Regional Cerebral Grey Matter Perfusion and Density in Men with Coronary Artery Disease
por: MacIntosh, Bradley J., et al.
Publicado: (2014)

Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach
por: Ruthirakuhan, Myuri, et al.
Publicado: (2022)

Kynurenine and depressive symptoms in a poststroke population
por: Bensimon, Kira, et al.
Publicado: (2014)

Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation
por: Santiago, Calvin, et al.
Publicado: (2017)

Post-stroke Fatigue and Depressive Symptoms Are Differentially Related to Mobility and Cognitive Performance
por: MacIntosh, Bradley J., et al.
Publicado: (2017)

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
por: Gold, Allison B, et al.
Publicado: (2011)

APOE and dementia – resequencing and genotyping in 105,597 individuals
por: Rasmussen, Katrine L., et al.
Publicado: (2020)

The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis
por: Dinoff, Adam, et al.
Publicado: (2016)

Characterization of APOE and TOMM40 allele frequencies in the Japanese population
por: Nishimura, Akira, et al.
Publicado: (2017)

APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos‐investigation of neurocognitive aging (HCHS/SOL)
por: Granot‐Hershkovitz, Einat, et al.
Publicado: (2020)

Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease
por: Liu, Li, et al.
Publicado: (2018)

Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
por: Behl, Pearl, et al.
Publicado: (2014)

The decline of domiciliary dentistry
por: Emanuel, Robert, et al.
Publicado: (2021)

Generating Ecotrust: A Relational Response to the Infodemic
por: Hirschmann, Krista, et al.
Publicado: (2021)

Accuracy and Efficiency of Recording Pediatric Early Warning Scores Using an Electronic Physiological Surveillance System Compared With Traditional Paper-Based Documentation
por: Sefton, Gerri, et al.
Publicado: (2017)

The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease
por: Jia, Longfei, et al.
Publicado: (2020)

An initial framework for use of ultrasound by speech and language therapists in the UK: Scope of practice, education and governance
por: Allen, Jodi Elizabeth, et al.
Publicado: (2022)

SUN-313 Depression, Subjective Stress and Serum Osteocalcin Concentrations in People with Type 2 Diabetes Mellitus
por: Nguyen, Michelle My Linh, et al.
Publicado: (2020)

Provider Decisions and Patient Outcomes After Premature Metformin Discontinuation
por: Bradley, Jessica N., et al.
Publicado: (2017)

Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
por: Sun, Yu, et al.
Publicado: (2019)

Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
por: Dowlati, Yekta, et al.
Publicado: (2010)

Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress
por: Swardfager, W., et al.
Publicado: (2014)

Rates of lobar atrophy in asymptomatic MAPT mutation carriers
por: Chen, Qin, et al.
Publicado: (2019)

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
por: Jensen, Camilla Steen, et al.
Publicado: (2019)

Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
por: Langlois, Carolyn M., et al.
Publicado: (2019)

The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals
por: Salvadó, Gemma, et al.
Publicado: (2021)

Metformin Use in Practice: Compliance With Guidelines for Patients With Diabetes and Preserved Renal Function
por: Salber, Gregory J., et al.
Publicado: (2017)

Managing patients who decline to wear a face covering
por: Hoppenbrouwers, Rupert
Publicado: (2021)

Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease
por: Jun, Gyungah R., et al.
Publicado: (2022)

APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies
por: Wang, Tingting, et al.
Publicado: (2022)

THE COMPARISON OF DUAL TASK TIME AMONG APOE CARRIERS AGAINST NON-APOE CARRIERS IN AGING ADULTS
por: Diehl, Cody, et al.
Publicado: (2022)

Higher Cortisol Predicts Less Improvement in Verbal Memory Performance after Cardiac Rehabilitation in Patients with Coronary Artery Disease
por: Saleem, Mahwesh, et al.
Publicado: (2013)

Reactive or transgenic increase in microglial TYROBP reveals a TREM2‐independent TYROBP–APOE link in wild‐type and Alzheimer's‐related mice
por: Audrain, Mickael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gbvu7c08q5v8odsjn8hfri0a3j